Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Recent Stock Purchase II November 2016

As the financial headlines and talking heads all discuss a “rotational shift” in the stock market, we are suddenly presented with new buying opportunities in whole sectors as well as individual companies that have not been available to us in a long, long time.

We have already witnessed the entire REIT sector, especially health REITs, fall off a cliff in recent weeks giving us more attractive buying opportunities in some amazing companies such as LTC Properties Inc (NYSE:LTC), Ventas, Inc. (NYSE:VTR), Welltower Inc (NYSE:HCN), Omega Healthcare Investors Inc (NYSE:OHI), HCP, Inc. (NYSE:HCP), and more.

stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

Matej Kastelic/

Of course, the consumer staples have not been spared either, as many traditionally-expensive stocks have started to fall back to earth, giving us some better prices, values and yields. Names like Procter & Gamble Co (NYSE:PG), Kimberly Clark Corp (NYSE:KMB), Colgate-Palmolive Company (NYSE:CL), Clorox Co (NYSE:CLX), and many more are all down over the last month. I think it’s safe to say that as long-term dividend investors, we wouldn’t mind seeing these consumer staples continue to fall further as the sector as a whole rarely offers us “sales.”

I am continuing to watch several names within the consumer staples sector and have made a second buy in as many weeks this month. It’s been a while since I have made back-to-back purchases one week after the other, but as we all know “Every Dollar Counts,” which is why I am continuing to put whatever cash I have to work for me in my dividend growth portfolios. With that being said let’s take a look at my recent stock purchase:

I have added to my ROTH account 15.0000 shares at $39.09 for a total investment of $586.35 in Unilever PLC (ADR) (NYSE:UL). With this recent purchase my ROTH account holdings in Unilever PLC (ADR) (NYSE:UL) now totals 85.5645 shares for a value of $3,350.71.

Unilever PLC (ADR) (NYSE:UL) was one of my picks in my November stock considerations and under $40 a share is a price I like and am willing to pay. This relatively small buy was commission free.

Follow Unilever Plc (NYSE:UL)
Trade (NYSE:UL) Now!

What do you think about my recent buy? Are you planning to rotate into the newly “hot” sectors or pick up some beaten-down dividend stalwarts instead? Please let me know.

Disclosure: Long VTR, HCN, HCP, PG, KMB, CL, CLX, UL

Note: This article is written by DivHut. Check out more of the site’s dividend investing content at

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.